
Technology
Cellular rejuvenation at scale
Integrated systems for measuring, improving and monitoring aging intervention
Foundation
Four pillars of precision longevity
Y Fountain integrates biology, computation, and artificial intelligence into a closed-loop system for cellular rejuvenation.

Discovery
High-throughput anti-aging drug discovery
High Throughput Screening Platform develops drugs that extend cellular lifespan. Our platform tests thousands of candidates in weeks, not years.

Development
Dietary supplement product development
Precision formulations support desirable biology during age-reversible interventions. Agile supplements target specific aging pathways with evidence-backed components.

Innovation
Proprietary and patented longevity platform
Years of research yields our methods. Patented technologies to cellular rejuvenation and compound intervention enable our competitive advantage.

Integration
Biology, automation, and artificial intelligence
Seamless integration of lab science, robotic systems, and machine learning creates a feedback loop. Data drives every decision.
Technology
High-Throughput Screening Platform
Traditional drug discovery takes 1-2 compounds every two weeks. Y Fountain screens over 8000+ compounds in the same timeframe, using smart resource Manager as a driver toward longevity.

High Throughput Screening Platform DAP - HTS

Traditional Approach
| Feature | DAP-HTS Platform | Traditional Approach |
|---|---|---|
| Compounds per Cycle | 8,000+ | 1-2 |
| Screening Speed | 4,000x faster | Baseline |
| Automation Level | Fully automated | Manual |
| Scalability | Highly scalable | Limited |
Yeast is the gold standard model for cellular aging research—its replicative lifespan mirrors fundamental aging processes conserved across species. As mother cells divide and age, daughter cells inherit the burden of time. Our patented Daughter Arresting Program (DAP) leverages this biological process to power our high-throughput screening platform, enabling drug screening over 4,000 times more efficiently than traditional methods.

Platform Validation
Validated by Known Anti-Aging Compounds
Our DAP-based screening platform successfully identifies established anti-aging compounds such as rapamycin, confirming its accuracy and reliability for novel drug discovery.

Strategy
Multi-pathway approach to aging intervention
Aging is not a single process but a cascade of interconnected biological failures. Pathway dysregulation links to age-associated diseases. Single compounds cannot address this complexity. Y Fountain targets multiple hallmarks simultaneously through precision compound combinations.
Targeting hallmarks of aging, including:
AI Technology
Our Proprietary AI Models for Baseline and Intervention Evaluation
AI models based on human blood omics data accurately predict survival, enabling precise assessment of biological age and intervention effectiveness.

Measurement
Track your biological age with precision
Our proteomic aging clock quantifies changes in biological aging based on internal molecular signals. Before-and-after comparisons enable objective assessment of intervention impact.
Baseline assessment
Initial blood omics establish your starting biological age and aging trajectory.
Visible progress
Follow-up measurements quantify improvement in years reversed, not just biomarker shifts.

Platform scale and scientific rigor in numbers
Compounds screened weekly
Four-thousand-fold improvement over traditional methods
Closed-loop feedback
Every outcome improves the next intervention
Omics examined
With our proprietary AI models
Contact us
Discover how precision longevity through cellular rejuvenation transforms aging intervention
